CTLM


Also found in: Acronyms.

CTLM

Imaging Computed tomography laser mammography A diagnostic technique using lasers to produce a 3-D cross-sectional image of the breast without x-rays. See Mammography.
References in periodicals archive ?
We collected data from 25 SMLs from 23 of the schools that participated in the final year of the CTLM project (Intake 4).
The CTLM system has global certifications and licences from the European CE mark, CMDCAS Canadian Health screening, China SFDA, India, UL and ISO 13485.
The contiguous, cross-sectional slices allow the CTLM system to create a three-dimensional image of the breast that is viewed on a computer screen.
CTLM system has received international certifications and licenses from the European CE mark, CMDCAS Canadian Health screening, China SFDA, India, UL, and ISO 13485.
The CTLM breast imaging system creates 3-D images of the breast via a non-invasive procedure that does not expose the patient to ionising radiation or painful breast compression.
The 3-D imaging technique used is unique to the CTLM system, which is vital to detecting breast abnormalities by providing the radiologist with additional information that may assist with a more precise diagnosis.
Fluorescence Markers" is a compound that the company is currently studying in conjunction with major pharmaceutical companies as an advanced diagnostic feature to be used with the company's laser mammography system: The CTLM in combination with the fluorescent feature has the potential to be used with photodynamic therapy to aid in the treatment of breast cancer.
The CTLM system has received certification and licenses to sell internationally European CE marking, CMDCAS Canadian License, China SFDA, ISO 13485:2003, EC-full quality assurance certificate and FDA export certification.
His marketing expertise and business development background will be beneficial for the expansion of the CTLM system and its position in the market place.
IDSI) (OTCBB:IMDS) a pioneer in optical breast imaging announced that it has received notification from the Food and Drug Administration (FDA) that the review of the company's Section 510(k) pre-market notification application of its CTLM system has been completed and categorized as a Class III device requiring a Premarket Approval application.
IDSI) (OTCBB:IMDS) a pioneer in optical breast imaging, announced today that it has signed an exclusive distribution agreement with National Diagnostic Service and Management, LLC (NDSM) of Novi, Michigan and its affiliate Phoenix Med of Moscow, Russia to promote its CTLM systems throughout Russia.
The scientific advisory panel will be a valuable resource for IDSI in designing clinical studies, suggesting product improvements, and proposing new applications for CTLM technology.